Literature DB >> 34985969

Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer's disease.

Chae Kim1, Tracy Haldiman1, Sang-Gyun Kang2, Lenka Hromadkova1, Zhuang Zhuang Han2, Wei Chen1,3, Frances Lissemore4, Alan Lerner4, Rohan de Silva5, Mark L Cohen1,3, David Westaway2, Jiri G Safar1,4.   

Abstract

Although genetic factors play a main role in determining the risk of developing Alzheimer’s disease (AD), they do not explain extensive spectrum of clinicopathological phenotypes. Deposits of aggregated TAU proteins are one of the main predictors of cognitive decline in AD. We investigated the hypothesis that variabilities in AD progression could be due to diverse structural assemblies (strains) of TAU protein. Using sensitive biophysical methods in 40 patients with AD and markedly different disease durations, we identified populations of distinct TAU particles that differed in size, structural organization, and replication rate in vitro and in cell assay. The rapidly replicating, distinctly misfolded TAU conformers found in rapidly progressive AD were composed of ~80% misfolded four-repeat (4R) TAU and ~20% of misfolded 3R TAU isoform with the same conformational signatures. These biophysical observations suggest that distinctly misfolded population of 4R TAU conformers drive the rapid decline in AD and imply that effective therapeutic strategies might need to consider not a singular species but a cloud of differently misfolded TAU conformers.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34985969      PMCID: PMC9549419          DOI: 10.1126/scitranslmed.abg0253

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   19.319


  110 in total

Review 1.  New generation QuIC assays for prion seeding activity.

Authors:  Christina D Orrù; Jason M Wilham; Sarah Vascellari; Andrew G Hughson; Byron Caughey
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

2.  Selective precipitation of prions by polyoxometalate complexes.

Authors:  In Su Lee; Jeffrey R Long; Stanley B Prusiner; Jiri G Safar
Journal:  J Am Chem Soc       Date:  2005-10-12       Impact factor: 15.419

3.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; David Peretz; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

4.  Diagnosis of human prion disease.

Authors:  Jiri G Safar; Michael D Geschwind; Camille Deering; Svetlana Didorenko; Mamta Sattavat; Henry Sanchez; Ana Serban; Martin Vey; Henry Baron; Kurt Giles; Bruce L Miller; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

5.  Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment.

Authors:  Curtis Tatsuoka; Huiyun Tseng; Judith Jaeger; Ferenc Varadi; Mark A Smith; Tomoko Yamada; Kathleen A Smyth; Alan J Lerner
Journal:  Alzheimers Res Ther       Date:  2013-03-06       Impact factor: 6.982

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Rapidly Progressive Alzheimer's Disease in Two Distinct Autopsy Cohorts.

Authors:  Jagan A Pillai; Brian S Appleby; Jiri Safar; James B Leverenz
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease.

Authors:  Diego Sepulveda-Falla; Lucia Chavez-Gutierrez; Erik Portelius; Jorge I Vélez; Simon Dujardin; Alvaro Barrera-Ocampo; Felix Dinkel; Christian Hagel; Berta Puig; Claudio Mastronardi; Francisco Lopera; Bradley T Hyman; Kaj Blennow; Mauricio Arcos-Burgos; Bart de Strooper; Markus Glatzel
Journal:  Acta Neuropathol       Date:  2020-12-14       Impact factor: 17.088

9.  Acquisition of drug resistance and dependence by prions.

Authors:  Anja M Oelschlegel; Charles Weissmann
Journal:  PLoS Pathog       Date:  2013-02-07       Impact factor: 6.823

10.  Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation.

Authors:  Nathalie Daude; Chae Kim; Sang-Gyun Kang; Ghazaleh Eskandari-Sedighi; Tracy Haldiman; Jing Yang; Shelaine C Fleck; Erik Gomez-Cardona; Zhuang Zhuang Han; Sergi Borrego-Ecija; Serene Wohlgemuth; Olivier Julien; Holger Wille; Laura Molina-Porcel; Ellen Gelpi; Jiri G Safar; David Westaway
Journal:  Acta Neuropathol       Date:  2020-03-26       Impact factor: 17.088

View more
  4 in total

1.  Fluent molecular mixing of Tau isoforms in Alzheimer's disease neurofibrillary tangles.

Authors:  Aurelio J Dregni; Pu Duan; Hong Xu; Lakshmi Changolkar; Nadia El Mammeri; Virginia M-Y Lee; Mei Hong
Journal:  Nat Commun       Date:  2022-05-27       Impact factor: 17.694

Review 2.  Rapidly progressive dementias - aetiologies, diagnosis and management.

Authors:  Peter Hermann; Inga Zerr
Journal:  Nat Rev Neurol       Date:  2022-05-04       Impact factor: 44.711

Review 3.  Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.

Authors:  Amy R Nelson
Journal:  Front Aging Neurosci       Date:  2022-04-18       Impact factor: 5.702

Review 4.  Populations of Tau Conformers Drive Prion-like Strain Effects in Alzheimer's Disease and Related Dementias.

Authors:  Lenka Hromadkova; Mohammad Khursheed Siddiqi; He Liu; Jiri G Safar
Journal:  Cells       Date:  2022-09-26       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.